Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.28
-0.88 (-4.16%)
At close: Dec 5, 2025, 4:00 PM EST
20.26
-0.02 (-0.10%)
After-hours: Dec 5, 2025, 5:01 PM EST
Neurogene Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 314 | 340 | 249 | - | - |
| Market Cap Growth | 22.95% | 36.64% | - | - | - |
| Enterprise Value | 59 | 214 | 452 | - | - |
| Last Close Price | 20.28 | 22.86 | 19.38 | - | - |
| PE Ratio | - | - | 18.20 | - | - |
| PS Ratio | - | 367.11 | - | - | - |
| PB Ratio | 1.13 | 1.09 | 1.34 | - | - |
| P/TBV Ratio | 1.18 | 1.09 | 1.34 | - | - |
| EV/Sales Ratio | - | 231.03 | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.08 | 0.05 | 0.06 |
| Asset Turnover | - | 0.00 | - | - | - |
| Quick Ratio | 18.10 | 20.65 | 8.61 | 12.48 | 6.57 |
| Current Ratio | 18.39 | 20.84 | 8.72 | 12.74 | 6.81 |
| Return on Equity (ROE) | -42.25% | -30.28% | -25.52% | -59.77% | - |
| Return on Assets (ROA) | -26.91% | -18.47% | -20.94% | -33.52% | - |
| Return on Capital (ROIC) | -28.54% | -19.69% | -22.83% | -36.31% | - |
| Return on Capital Employed (ROCE) | -35.60% | -25.70% | -27.80% | -55.10% | -55.80% |
| Earnings Yield | -27.10% | -22.13% | -14.61% | - | - |
| FCF Yield | -24.96% | -21.03% | -20.82% | - | - |
| Buyback Yield / Dilution | -60.75% | -277.22% | -1080.37% | 90.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.